Tratamientos Térmicos Minguet S.L. empresa con actividad en tratamientos térmicos de acero y fabricación de cribas y reparación de maquinaria. Un equipo de personas ampliamente comprometido con el cambio, liderazgo centrado en el desarrollo organizacional con principios, mezclado con un gran compromiso económico, social y ambiental con nuestros clientes, hacen de Tratermi una empresa sólida y confiable en la producción de piezas en Acero. Tratamientos Térmicos Minguet S.L. es una empresa que posee claras definiciones de sus valores, desarrollando actividades industriales y comerciales con importante presencia y foco en la economía de nuestro país. La clave para alcanzar los objetivos propuestos son la organización y el trabajo en equipo, lo cual se vera reflejado en la satisfacción de los clientes.
Bienvenidos
TTM
Tratamientos Térmicos Minguet
Tratamientos Térmicos de Acero
EMPRESA TRATAMIENTOS Tratamientos Térmicos Tratamientos Termoquímicos LABORATORIO CALIDAD LOCALIZACIÓN CONTACTO LINKS FOTOSCopyright 2009
Tratamientos Térmicos Minguet S.L C/ En proyecto, nº 11 y 13 46470 Albal (VALENCIA) Telf.- 96 127 35 76 Fax: 96 127 55 30 Email: info@tratermin.com.
 
Home site map contact us subscribe via rss amyotrophic lateral sclerosis autism bone marrow failure breast cancer defense medical research and development duchenne muscular dystrophy genetic studies of food allergies gulf war illness lung cancer multiple sclerosis neurofibromatosis ovarian cancer peer reviewed cancer peer reviewed medical peer reviewed orthopaedic prostate cancer psychological health/traumatic brain injury spinal cord injury tuberous sclerosis complex previously funded research programs program announcements start pre-application synopsis of current program announcements program announcement archives frequently asked questions what is the role of the consumer reviewer? viagra for cheap buy cheap viagra Am i eligible to be a consumer reviewer? reviews viagra viagra viagra reviews viagra viagra viagra Consumer stories frequently asked questions consumer brochure in the news press releases research highlights & results consumer stories video library annual reports program booklets award books other publications funding history funding process two-tiered review process program evaluation our team contact us job opportunities home  ›   research programs  ›   neurofibromatosis  ›   research highlights neurofibromatosis research highlights 2012 neurofibromatosis clinical trials consortium improving cognitive and behavioral function in nf1 genetically engineered mice defining quality of life in nf2 2011: may is neurofibromatosis awareness month 2010: induced pluripotent stem cells as potential therapeutic agents in nf1 identification of the cellular and molecular mechanisms underlying the osseous manifestations of nf1 in murine and human systems characterizing ken: a novel nf2/merlin protein complex modulating growth control identification of a new target and treatment compound for nf1-associated cancer 2009: congressionally directed medical research program (cdmrp)-funded research presented at the 2009 neurofibromatosis (nf) conference hu is making the decisions? viagra online without prescription viagra 10 mg when to take it Mouse model replicates skeletal abnormalities of neurofibromatosis type i finding the positive in negative feedback 2008: a pain in the neuroma: using a new pain model to find ways to stop the vicious cycle molecular mechanism of nf1 vasculopathy neurofibromin ubiquitin ligase: regulation and function new hope from a glimmer: photodynamic therapy for the treatment of plexiform neurofibromas functional role of. generic viagra online eli lilly viagra coupon order viagra online non prescription viagra